These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21698655)

  • 21. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
    J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput analysis of protein/peptide complexes by immunoprecipitation and automated LC-MS/MS.
    Lin Z; Crockett DK; Lim MS; Elenitoba-Johnson KS
    J Biomol Tech; 2003 Jun; 14(2):149-55. PubMed ID: 14676314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural mass spectrometry in protein therapeutics discovery.
    Kim YJ; Doyle ML
    Anal Chem; 2010 Sep; 82(17):7083-9. PubMed ID: 20698501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of mass spectrometry in drug metabolism: 50 years of progress.
    Wen B; Zhu M
    Drug Metab Rev; 2015 Feb; 47(1):71-87. PubMed ID: 25639893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative determination of peptide drug in human plasma samples at low pg/ml levels using coupled column liquid chromatography-tandem mass spectrometry.
    Lövgren U; Johansson S; Jensen LS; Ekström C; Carlshaf A
    J Pharm Biomed Anal; 2010 Nov; 53(3):537-45. PubMed ID: 20456896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical proteomics: liquid chromatography-mass spectrometry purification systems.
    Henry M; Meleady P
    Methods Mol Biol; 2011; 681():473-83. PubMed ID: 20978984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intact protein analysis in the biopharmaceutical field.
    Staub A; Guillarme D; Schappler J; Veuthey JL; Rudaz S
    J Pharm Biomed Anal; 2011 Jun; 55(4):810-22. PubMed ID: 21334842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples.
    Zhang Y; Li N; Brown PW; Ozer JS; Lai Y
    Rapid Commun Mass Spectrom; 2011 Jun; 25(12):1715-24. PubMed ID: 21598331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent studies on the electrospray ionisation mass spectrometric behaviour of selected nitrogen-containing drug molecules and its application to drug analysis using liquid chromatography-electrospray ionisation mass spectrometry.
    Smyth WF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):1-20. PubMed ID: 16095984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches.
    Liu DQ; Hop CE
    J Pharm Biomed Anal; 2005 Feb; 37(1):1-18. PubMed ID: 15664738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.
    Wabnitz PA; Loo JA
    Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications.
    Baumann A; Karst U
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):715-31. PubMed ID: 20370599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerator mass spectrometry offers new opportunities for microdosing of peptide and protein pharmaceuticals.
    Salehpour M; Ekblom J; Sabetsky V; Håkansson K; Possnert G
    Rapid Commun Mass Spectrom; 2010 May; 24(10):1481-9. PubMed ID: 20411588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an information-rich LC-MS/MS database for the analysis of drugs in postmortem specimens.
    Liu HC; Liu RH; Ho HO; Lin DL
    Anal Chem; 2009 Nov; 81(21):9002-11. PubMed ID: 19788251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics profile of cellular response to chiral drugs: prospects for pharmaceutical applications.
    Bun Ching C; Zhang J; Sui J; Ning Chen W
    Proteomics; 2010 Feb; 10(4):888-93. PubMed ID: 19953539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced metabolite identification with MS(E) and a semi-automated software for structural elucidation.
    Bonn B; Leandersson C; Fontaine F; Zamora I
    Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3127-38. PubMed ID: 20941759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of polar drugs in human plasma with liquid chromatography-tandem mass spectrometry.
    Deng P; Chen X; Zhong D
    Bioanalysis; 2009 Apr; 1(1):187-203. PubMed ID: 21083196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry.
    Ma S; Subramanian R
    J Mass Spectrom; 2006 Sep; 41(9):1121-39. PubMed ID: 16967439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
    Maurer HH
    Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of food proteins and peptides by mass spectrometry-based techniques.
    Mamone G; Picariello G; Caira S; Addeo F; Ferranti P
    J Chromatogr A; 2009 Oct; 1216(43):7130-42. PubMed ID: 19699482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.